Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000898430-07-003032
Filing Date
2007-08-16
Accepted
2007-08-16 19:36:53
Documents
1
Period of Report
2007-08-14

Document Format Files

Seq Description Document Type Size
1 AUGUST PURCHASE #2 rrd169850.html 4  
1 AUGUST PURCHASE #2 rrd169850.xml 4 9499
  Complete submission text file 0000898430-07-003032.txt   11540
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Issuer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 750 BATTERY ST STE 600 SAN FRANCISCO CA 94111
Business Address 410 WEST HARRISON ST SEATTLE WA 98119-4007 2062817001
CRAVES FRED B (Reporting) CIK: 0001014095 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16614 | Film No.: 071063651